GEHC Stock News & Catalysts – GE HealthCare Technologies

FEATURED

GE HealthCare reinforces leadership in AI with Lung Guidance and AutoAS on Vscan Air for point of care ultrasound assessments

New AI-assisted capabilities expand the Vscan Air suite with lung scan guidance and support for the assessment of moderate-to-severe aortic stenosis GE HealthCare (NASDAQ:GEHC) today announced two new AI-assisted

Summary

Nov 3, 2026, 9:00 AM ·Business Wire

RECENT

GE HealthCare debuts Allia Celeo, a ceiling-mounted interventional system designed for smooth procedural flow and AI-powered precision imaging

Extra-wide-bore, cable-less ceiling gantry and real-time digital twin aim to keep cases moving, regardless of procedure type or patient size AI-powered precision imaging designed to automatically balance image

Nov 1, 2026, 12:35 PM ·Business Wire

GE HealthCare reports third quarter 2026 financial results

Delivers top- and bottom-line growth ahead of Company expectations and raises full-year 2026 guidance Revenue growth of 7.2%, and Organic revenue growth* of 6.2% Organic orders growth of 4.0%, book-to-bill of

Oct 28, 2026, 6:20 AM ·Business Wire

GE HealthCare announces five new global collaborations to advance the next generation of theranostics imaging

Leading institutions will evaluate StarGuide GXi across quantitative imaging, dynamic imaging and emerging theranostic applications Clinical experience from more than 1,000 patient studies was established ahead of

Oct 20, 2026, 12:39 PM ·Business Wire

GE HealthCare expands general imaging ultrasound portfolio with LOGIQ Focus, elevating everyday ultrasound performance

LOGIQ Focus is powered by cSound Architecture and combined with comprehensive digital tools to deliver advanced image quality and premium-level performance for confident, everyday full-body ultrasound GE HealthCare

Oct 19, 2026, 9:00 AM ·Business Wire

Research conducted at University of Michigan published in Anesthesia & Analgesia Practice demonstrates GE HealthCare End-tidal Control software may help to reduce fresh gas flow

Study of nearly 13,000 adult general anesthesia cases found clinician use of End-tidal Control softwarei at a large multisite academic medical center was associated with a reduction in fresh gas flow, sevoflurane

Oct 16, 2026, 8:47 AM ·Business Wire

GE HealthCare's MINItrace™ Magni achieves CE Mark; Copper-64 expands PETtrace™ Solid Target Platform beyond Gallium-68

MINItrace Magni combines a compact, self-shielded design with automated operation to help healthcare providers establish and expand local production of radioisotopes used in PET tracers Copper-64 expands the

Oct 15, 2026, 8:00 AM ·Business Wire

GE HealthCare to announce third quarter 2026 results on October 28, 2026

GE HealthCare (NASDAQ:GEHC) will announce its third quarter 2026 financial results before the market opens on Wednesday, October 28, 2026. The GE HealthCare management team will also host a conference call and webcast

Oct 7, 2026, 8:00 AM ·Business Wire

Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of GE HealthCare Technologies Inc. ("GE

Oct 5, 2026, 11:00 AM ·Globe Newswire

GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of GE HealthCare Technologies Inc. ("GE HealthCare" or the "Company") (NASDAQ:GEHC)

Oct 5, 2026, 9:00 AM ·Globe Newswire

GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.

Broadens GE HealthCare's footprint in the U.S. radiopharmaceutical industry, drives patient access to F18 labeled Positron Emission Tomography (PET) radiopharmaceuticals and enhances exposure to new high-growth

Oct 5, 2026, 8:00 AM ·Business Wire

Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES, Oct. 02, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of of GE HealthCare Technologies Inc. ("GE HealthCare" or the "Company") (NASDAQ:GEHC) on

Oct 2, 2026, 5:30 PM ·Globe Newswire

GE HealthCare announces cash dividend increase for third quarter of 2026

The Board of Directors of GE HealthCare Technologies Inc. (NASDAQ:GEHC) today declared a cash dividend of $0.04 per share of Common Stock for the third quarter of 2026, an increase of 14% from the previous quarter. The

Sep 22, 2026, 5:25 PM ·Business Wire

GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors

GE HealthCare (NASDAQ:GEHC) today announced the appointment of Pascal Desroches, Senior Executive Vice President and Chief Financial Officer (CFO) of AT&T (NYSE:T), a Fortune 50 company, to its Board of Directors,

Sep 22, 2026, 4:05 PM ·Business Wire

LOS ANGELES, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of GE HealthCare Technologies Inc. ("GE

Sep 17, 2026, 11:00 AM ·Globe Newswire

GE HealthCare Technologies Inc. GEHC · News